Table 1 Patient data to TMA
Patient | Age | FIGO stage | Histology | HPV positivity |
|---|---|---|---|---|
1 | 37 | II/A | Adenosquamous carcinoma | - |
2 | 51 | I/B | Squamous cell carcinoma | - |
3 | 42 | II/A | Squamous cell carcinoma | - |
4 | 48 | II/B | Squamous cell carcinoma | HPV18 |
5 | 39 | II/B | Squamous cell carcinoma | HPV 16, 18 |
6 | 41 | II/A | Squamous cell carcinoma | HPV16 |
7 | 38 | II/B | Squamous cell carcinoma | HPV16 |
8 | 59 | II/B | Squamous cell carcinoma | HPV16 |
9 | 39 | II/B | Squamous cell carcinoma | HPV16 |
10 | 39 | I/B | Squamous cell carcinoma | HPV16 |
11 | 71 | II/A | Clear cell carcinoma | HPV16 |
12 | 51 | II/A | Squamous cell carcinoma | HPV16 |
13 | 44 | II/B | Squamous cell carcinoma | HPV16 |
14 | 42 | II/A | Squamous cell carcinoma | HPV16 |
15 | 45 | II/B | Squamous cell carcinoma | HPV16 |
16 | 32 | I/B | Squamous cell carcinoma | HPV16 |
17 | 55 | II/B | Squamous cell carcinoma | - |
18 | 56 | II/B | Squamous cell carcinoma | HPV16 |
19 | 57 | II/B | Squamous cell carcinoma | HPV16 |
20 | 44 | II/B | Squamous cell carcinoma | HPV16 |
21 | 35 | I/B | Squamous cell carcinoma | HPV16 |
22 | 66 | II/B | Squamous cell carcinoma | HPV16 |
23 | 57 | II/A | Squamous cell carcinoma | HPV16 |
24 | 38 | II/B | Squamous cell carcinoma | HPV16 |
25 | 40 | II/B | Squamous cell carcinoma | HPV16 |
26 | 52 | II/B | Squamous cell carcinoma | HPV16 |
27 | 62 | II/B | Squamous cell carcinoma | HPV16 |
28 | 57 | II/B | Squamous cell carcinoma | HPV16 |
29 | 54 | II/B | Squamous cell carcinoma | HPV16 |